Alissar Monzer
Overview
Explore the profile of Alissar Monzer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
272
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Babeker H, Njotu F, Pougoue Ketchemen J, Monzer A, Tikum A, Doroudi A, et al.
J Nucl Med
. 2025 Feb;
PMID: 39978811
Nectin-4 is an overexpressed biomarker in 60%-70% of triple-negative breast cancer (TNBC) cases and an ideal target for radiotherapy and PET imaging. In this study, theranostic radioimmunoconjugates were developed using...
2.
Pougoue Ketchemen J, Njotu F, Babeker H, Monzer A, Nwangele E, Tikum A, et al.
Clin Cancer Res
. 2024 Dec;
31(4):685-696.
PMID: 39670857
Purpose: There is overwhelming interest to use actinium-225 ([225Ac]Ac) to develop targeted α therapies. Antibody-drug conjugates (ADC) are highly cytotoxic. Combining [225Ac]Ac with an ADC to develop an antibody-drug radioconjugate...
3.
Njotu F, Pougoue Ketchemen J, Babeker H, Henning N, Tikum A, Nwangele E, et al.
Eur J Nucl Med Mol Imaging
. 2024 Dec;
52(4):1305-1320.
PMID: 39627348
Purpose: We report the preclinical evaluation of potent long-acting [Ac]Ac-EBTATE against SSTR2-positive small cell lung cancer (SCLC) and pancreatic neuroendocrine tumors (pan-NETs). Methods: The pharmacokinetic, biodistribution, and safety studies were...
4.
Monzer A, Ghamlouche F, Wakimian K, Ballout F, Al Bitar S, Yehya A, et al.
Pharmacol Rep
. 2024 Nov;
77(1):229-246.
PMID: 39551911
Background: Colorectal cancer (CRC) remains one of the most frequently diagnosed and life-threatening malignancies worldwide. CRC's high recurrence rates and drug resistance have been correlated with a subpopulation of dormant...
5.
Monzer A, Wakimian K, Ballout F, Al Bitar S, Yehya A, Kanso M, et al.
World J Gastroenterol
. 2022 Sep;
28(33):4787-4811.
PMID: 36156922
Background: Colorectal cancer (CRC) is the second leading cause of cancer-related mortality. Cancer stem cells (CSCs) in CRC, which are spared by many chemotherapeutics, have tumorigenic capacity and are believed...
6.
Al Bitar S, Ballout F, Monzer A, Kanso M, Saheb N, Mukherji D, et al.
Cancers (Basel)
. 2022 Mar;
14(6).
PMID: 35326517
Resistance of cancer cells and normal tissue toxicity of ionizing radiation (IR) are known to limit the success of radiotherapy. There is growing interest in using IR with natural compounds...
7.
Cheaito K, Bahmad H, Hadadeh O, Msheik H, Monzer A, Ballout F, et al.
Oncol Lett
. 2021 Nov;
23(1):6.
PMID: 34820005
Three-dimensional (3D) organoid culture systems are emerging as potential reliable tools to investigate basic developmental processes of human disease, especially cancer. The present study used established and modified culture conditions...
8.
Azar J, Bahmad H, Daher D, Moubarak M, Hadadeh O, Monzer A, et al.
Int J Mol Sci
. 2021 Jul;
22(14).
PMID: 34299287
Organoids represent one of the most important advancements in the field of stem cells during the past decade. They are three-dimensional in vitro culturing models that originate from self-organizing stem...
9.
Bahmad H, Chalhoub R, Harati H, Bou-Gharios J, Assi S, Ballout F, et al.
Pharmacol Rep
. 2020 Oct;
73(1):211-226.
PMID: 33030673
Background: Neuroblastoma (NB) is the most frequently diagnosed extracranial solid tumor among the pediatric population. It is an embryonic tumor with high relapse rates pertaining to the presence of dormant...
10.
Ballout F, Monzer A, Fatfat M, El Ouweini H, Jaffa M, Abdel-Samad R, et al.
Oncotarget
. 2020 Aug;
11(31):2959-2972.
PMID: 32821342
The high recurrence rates of colorectal cancer have been associated with a small population of cancer stem cells (CSCs) that are resistant to the standard chemotherapeutic drug, 5-fluorouracil (5FU). Thymoquinone...